U.S. Markets open in 7 hrs 2 mins

The global insulin pens market is expected to reach US$ 8,862.0 Mn in 2027 from US$ 4,199.7 in 2018. The market is estimated to grow with a CAGR of 8.8% from 2019-2027

Insulin Pens Market to 2027 – Global Analysis and Forecasts by Product Type, Application, Distribution Channel and Geography. The global insulin pens market is expected to reach US$ 8,862. 0 Mn in 2027 from US$ 4,199.

New York, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Insulin Pens Market to 2027 - Global Analysis and Forecasts By Product Type ; Application ; Distribution Channel and Geography" - https://www.reportlinker.com/p05862147/?utm_source=GNW
7 in 2018. The market is estimated to grow with a CAGR of 8.8% from 2019-2027.
The key factors that are driving the growth of the market are rising incidence of diabetes, growing geriatric population, and increasing adoption of insulin pens over conventional vials and syringes.However, the factors restraining the market growth are high cost of insulin pens and the availability of alternatives to insulin pens in the market.

On the other hand, the high potential for market growth in emerging economies is one of the growth opportunities for market players.
In recent years, there has been considerable development in the field of medical drug delivery devices.Insulin administration is a standard procedure in the diabetic population.

Traditional insulin syringes have several disadvantages that include the experience of pain by patients due to repeated pricks, discomfort in carrying both insulin bottle as well as a syringe, risk of needle re-use associated infections and needle-stick injuries as well as difficulty in delivering a mixture of two or more liquids together in one syringe.Additionally, self-administration of insulin through syringes and vials is time-taking and difficult that has reduced the adoption of conventional insulin injection methods over the past years and led to increased adoption of injection pens.

Thus, the inclination of patients towards insulin injection pens over syringes is expected to be a driving factor to foster the growth of insulin pens market.
Global insulin pens market was segmented by product type, application, and end user.The insulin pens market on the basis of product type is segmented in to disposable and reusable.

In 2018, the reusable segment held the largest share of the market, by product type. Moreover, the smart insulin pen caps segment of insulin pens market is expected to witness growth in its demand at a fastest CAGR of 9.9% during 2019 to 2027. Various start-ups and established manufacturers are coming up with the concepts of smart insulin pen caps that turns conventional pen injectors into connected devices that helps to capture treatment information such as date, dose and time of the injection. The ability of these devices to convert traditional pens into technologically advanced injection pens are expected to account for the growth of the segment in the global insulin pens market.
Some of the major primary and secondary sources included in the report for the insulin pens market are World Health Organization, American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation, and others.
Read the full report: https://www.reportlinker.com/p05862147/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

  • Business
    Barrons.com

    The Dow Dropped 1000 Points Monday. Here’s What History Says Happens Next.

    From a technical perspective, the S&P 500 should find support near its Jan. 31 low of 3225.52, according to Macro Risk Advisors' John Kolovos. That's right about where the S&P 500, at 3,225.89, closed, and if that breaks a full-blown correction is likely in play. This is the type of distributive selling that will require a good and proper reset in price, sentiment and or time on a break,” he writes.

  • Suze Orman says investors should ‘rejoice’ at the Dow’s more-than-1,000-point tumble — here’s why
    Business
    MarketWatch

    Suze Orman says investors should ‘rejoice’ at the Dow’s more-than-1,000-point tumble — here’s why

    Author and personal-finance expert Suze Orman had a simple two-word answer to the question of how to react to a market that just shed more than 1,000 points on the back of growing uncertainties, including the spread of the coronavirus outbreak. Orman said Monday on CNBC that investors should stay the course and explained why she thought investors worried about their retirement savings after a historic downturn for the Dow Jones Industrial Average should welcome such selloffs.

  • Dow Jones Futures Rebound After Tech Titans Lead Stock Market Rally Sell-Off
    Business
    Investor's Business Daily

    Dow Jones Futures Rebound After Tech Titans Lead Stock Market Rally Sell-Off

    Mastercard stock and Moderna stock moved overnight on coronavirus news, while Tandem Diabetes reported earnings. Apple stock, AMD stock, Tesla stock, Nvidia stock, Google stock, Amazon stock and Microsoft stock were big drags on the broader market. The Dow Jones Industrial Average, S&P 500 index and Nasdaq composite all fell below their 50-day moving averages, suffering their worst losses in more than a year.

  • 'Flat earther' dies in rocket crash
    U.S.
    Associated Press Videos

    'Flat earther' dies in rocket crash

    A California man who said he wanted to fly to the edge of outer space to see if the world is round has died after his home-built rocket blasted off into the desert sky and plunged back to earth. Feb.

  • Business
    NerdWallet

    How the IRS Knows If You Cheat on Your Taxes

    Those forms, called information returns, typically are records of certain payments you received or made during the tax year that you usually need to report on your tax return. Some of the most common information returns are W-2s, which report wages earned from a job, and 1099s, which report money received for things such as freelance work, dividends or interest. But other money moves you make could put information returns in the IRS' mailbox, too, says Ignatius Jackson, a certified public accountant in Phoenix.

  • A pause after the plunge? U.S. stock futures rise, suggesting Tuesday gains
    Business
    MarketWatch

    A pause after the plunge? U.S. stock futures rise, suggesting Tuesday gains

    Stocks on Wall Street plunged Monday, but futures trading suggests a rebound — or a least a respite — on Tuesday. Dow Jones Industrial Average futures (YM00) rose more than 200 points on Tuesday, while S&P 500 futures (ES00) gained 0.8% and Nasdaq Composite futures (NQ00) added more than 1% A pause or bounce-back would not be unusual. The past 10 times that the S&P 500 index fell by as much as 3%, for example, it declined just 0.27%, on average, in the next trading session, according to Dow Jones Market Data.

  • Gilead Surges After WHO Comments on Virus Drug Testing
    Business
    Bloomberg

    Gilead Surges After WHO Comments on Virus Drug Testing

    Gilead's compound, remdesivir, has been rushed into a clinical trial in China, where the illness has infected tens of thousands of people. Remdesivir is the “one drug right now that we think may have efficacy,” Bruce Aylward, an assistant director-general at the World Health Organization, said at a briefing in Beijing. Gilead shares rose 4.6% to $72.90 on Monday, the highest closing level since October 2018.

  • Here are the worst-performing stocks Monday as investors panic over the coronavirus
    Business
    MarketWatch

    Here are the worst-performing stocks Monday as investors panic over the coronavirus

    a href="https://www.marketwatch.com/story/here-are-the-worst-performing-stocks-monday-as-investors-panic-over-the-coronavirus-2020-02-24? siteid=yhoof2" (UNH) -7.8% -5.5% -9.4% 18.0% American Express Co.

  • Why Fidelity 401(k) Millionaires Average $1.46 Mil Balances
    Business
    Investor's Business Daily

    Why Fidelity 401(k) Millionaires Average $1.46 Mil Balances

    The number of people with $1 million or more in 401(k) accounts in plans run by Fidelity Investments rose to a record 233,000. And the number of IRA millionaires — savers with balances of $1 million or more in accounts held at Fidelity — hit 208,000, also a record. Fidelity 401(k) Millionaire Traits In addition, Fidelity disclosed several of its 401(k) millionaires' traits: The average 401(k) balance for its millionaires reached $1,462,000.

  • Business
    Benzinga

    Warren Buffett On Monday's Market Plunge: 'That's Good For Us'

    Warren Buffett said in a CNBC interview Monday he prefers buying stocks at a cheaper price so Monday's sell-off is something "that's good for us." Buffett's annual chat with CNBC's Becky Quick coincided with a large sell-off in U.S. stocks as confirmed coronavirus cases are popping up in large numbers worldwide. But Buffett will be "buying on balance" and he "certainly won't" be selling any shares.

  • Exxon Drops to 15-Year Low Ahead of Annual Strategy Presentation
    Business
    Bloomberg

    Exxon Drops to 15-Year Low Ahead of Annual Strategy Presentation

    The shares have been under pressure since Exxon disclosed disappointing fourth-quarter results in late January and prospects for a near-term recovery were dimmed by the spreading coronavirus. Exxon fell 4.7% to close at $56.36 on Monday in New York as Brent crude tumbled to about $56 a barrel. Exxon has been scrutinizing employee-travel budgets since posting its worst quarterly profit in almost four years, people with knowledge of the matter told Bloomberg News earlier this month.

  • UnitedHealth stock plunges toward worst day in nearly 9 years as Sanders’ Nevada win stokes investor fear
    Business
    MarketWatch

    UnitedHealth stock plunges toward worst day in nearly 9 years as Sanders’ Nevada win stokes investor fear

    Shares of UnitedHealth Group Inc. plunged toward their worst day in nearly 9 years Monday, as the narrative around a potential Bernie Sanders nomination may have swung to negative from positive following the senator's surprisingly big win in Nevada. Other health insurer stocks also took deeper dives than the broader stock market in afternoon trading. Shares of Centene Corp. (CNC) , which provides programs and services to government-sponsored health-care programs, plunged 10.2% to pace the 492 of 505 stocks on the S&P 500 index (SPX)  that were losing ground.

  • J.P. Morgan: 2 “Strong Buy” Healthcare Stocks With Over 50% Upside
    Business
    TipRanks

    J.P. Morgan: 2 “Strong Buy” Healthcare Stocks With Over 50% Upside

    Digitization of the world we live in has disrupted the healthcare industry, giving rise to the healthcare information technology (IT) segment of the market. The emergence of this space and the technology it offers has transformed the way healthcare providers and organizations care for patients. Bearing this in mind, investing firm J.P. Morgan took a look at several healthcare IT names ahead of their upcoming fourth quarter earnings releases.

  • Asian markets extend losses as outbreak’s ripple effects spread
    Business
    MarketWatch

    Asian markets extend losses as outbreak’s ripple effects spread

    Shares were mostly lower in Asia on Tuesday after Wall Street suffered its worst session in two years, with the Dow Jones Industrial Average slumping more than 1,000 points on fears that a viral outbreak that began in China will weaken the world economy. “Stock markets around the world are beginning to price in what bond markets have been telling us for weeks — that global growth is likely to be impacted in a meaningful way due to fears of the coronavirus,” said Chris Zaccarelli, chief investment officer for Independent Advisor Alliance.

  • AMD Tests Support
    Business
    Investor's Business Daily Video

    AMD Tests Support

    AMD tumbled Monday, rebounding to close above 50-day line.

  • U.S. Stock Index Futures Gain on Possible Dip-Buying, New Drugs
    Business
    Bloomberg

    U.S. Stock Index Futures Gain on Possible Dip-Buying, New Drugs

    S&P 500 Index futures contracts expiring in March rose 0.9% as of 6:03 a.m. in London, while contracts climbed 0.7% for the Dow Jones Industrial Average and advanced 1.2% for the Nasdaq 100. Overnight, all three main U.S. stock benchmarks fell more than 3% amid growing concerns that the novel coronavirus is spreading more widely outside China. The S&P 500 dropped the most since February 2018 for the third consecutive day, its longest losing streak since December.

  • One of the market’s hottest stocks just bounced into the green to buck selloff
    Business
    MarketWatch

    One of the market’s hottest stocks just bounced into the green to buck selloff

    Virgin Galactic shares, which have been on a ridiculous tear lately, started Monday's session just like most stocks did — deep in the red. Yes, Richard Branson's Virgin Galactic (SPCE)saw its stock take a double-digit hit early, following the Dow Jones Industrial Average (DJIA)and the S&P 500 (SPX)into negative territory. But while the broader market failed to shake the coronavirus fears by the end of trading, Virgin Galactic, as you can see, caught a swarm of dip-buyers, who pushed the stock to a positive close on heavy volume.

  • 3 ‘Perfect 10’ Stocks to Consider When Coronavirus Fears Fade
    Business
    TipRanks

    3 ‘Perfect 10’ Stocks to Consider When Coronavirus Fears Fade

    In fact, using TipRanks' Best Stocks to Buy tool we managed to pinpoint 3 stocks in the sector that currently present perfect investing opportunities -- all receive a score of a “perfect 10." Let's get the lowdown. Lumentum has had a phenomenal 2019, with shares up over 90%. In the latest earnings report, the company posted revenue of $457.8 million, a year-over-year increase of 23%, beating the consensus calls for $452 million.

  • Palo Alto Earnings Guidance Falls Short, Cybersecurity Stock Plunges
    Business
    Investor's Business Daily

    Palo Alto Earnings Guidance Falls Short, Cybersecurity Stock Plunges

    Palo Alto Networks reported fiscal second-quarter revenue that fell far short of analyst estimates. The Palo Alto earnings news and weak guidance sent shares in the cybersecurity firm crashing in extended trading Monday. Earnings fell from the year-earlier period but topped views.

  • Business
    Barrons.com

    The Only 13 S&P 500 Stocks That Rose Today

    Monday was the worst day for the U.S. stock markets in two years. The S&P 500 index lost 3.4%, erasing its 2020 gains and more. All 11 of its sectors declined, led by energy's 4.6% drop.

  • Investors unable to access brokerage accounts as stocks fall — what you should know for your retirement accounts
    Business
    MarketWatch

    Investors unable to access brokerage accounts as stocks fall — what you should know for your retirement accounts

    Investors are advised not to change their investment portfolios when the market is volatile — some were forced to take that advice when they couldn't access their accounts Monday morning. Some Fidelity Investment users tweeted Monday morning that at the start of the trading day, they couldn't log in to their accounts, or when they did, they saw a $0 balance. This comes less than a week after Fidelity customers were unable to access their accounts, or came across with no balance for their 401(k) and other investment portfolios.

  • India To Buy $3 Billion In U.S. Weapons But This Key Deal Awaits
    Politics
    Investor's Business Daily

    India To Buy $3 Billion In U.S. Weapons But This Key Deal Awaits

    President Donald Trump said India will sign $3 billion in military deals with the U.S. Tuesday, while Boeing and Lockheed Martin remain in a dogfight to win a massive fighter jet deal. Defense stocks dropped. Earlier this month, the State Department approved the sale of a Raytheon Integrated Air Defense Weapon System, which includes radars and missiles, to India as part of a $1.87 billion package.

  • 4 Warren Buffett Holdings Trading Near 52-Week Lows
    Business
    GuruFocus.com

    4 Warren Buffett Holdings Trading Near 52-Week Lows

    According to current portfolio statistics, a Premium feature, four holdings of Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway Inc. NYSE:BRK.A)(NYSE:BRK.B) are trading near 52-week lows on Monday as markets around the globe grapple with accelerating coronavirus fears: United Airlines Holdings Inc. NASDAQ:UAL), General Motors Co. (NYSE:GM), Synchrony Financial (NYSE:SYF) and The Travelers Companies Inc.

  • Business
    Financial Times

    Coronavirus stock sell-off eases as Wall Street futures rise

    p In Asia, futures trading pointed to gains of as much as 1 per cent when Wall Street opens on Tuesday. That came after the S&P 500 dropped 3.4 per cent overnight, erasing its gains for the year after signs that the spread of the virus was accelerating outside of China in countries such as Italy,

  • Why This Is The Only Marijuana Stock A Top Pot Analyst Still Rates As A Buy
    Business
    Investor's Business Daily

    Why This Is The Only Marijuana Stock A Top Pot Analyst Still Rates As A Buy

    Marijuana stocks fell Monday as Cowen downgraded Aurora Cannabis stock and Tilray, but kept Canopy Growth stock as its only "outperform" rating, amid ongoing supply and cash difficulties in Canada's legal recreational rollout and better prospects in the U.S. In a research note on Monday, Cowen analyst Vivien Azer said issues that have hurt the industry — too few stores to sell weed, difficulty bringing illicit-market customers into the legal market — "do not appear to be fading as anticipated." Newer legal products, like edibles and vapes, are "likely not the elixir that the market was hoping for," she said. Factoring those issues together, Cowen also slashed its full-year sales forecast by 32% to 3.5 billion Canadian dollars ($2.63 billion) in legal cannabis sales.